Rice University Business Plan Competition Winners to Ring The NASDAQ Stock Market Closing Bell

ADVISORY, June 24, 2010 (GLOBE NEWSWIRE) --

What:

Rice Alliance for Technology and Entrepreneurship from Rice University will visit the NASDAQ MarketSite in New York City's Times Square to honor BiologicsMD, LLC., winners of the 2010 Rice University Business Competition.

BiologicsMD has developed OsteoFlor™, a new medication that builds better bones. It binds directly to bone, nearly tripling new bone growth. It requires less frequent dosing and is expected to have few, if any, side effects. Osteoporotic fractures strike 1 of 2 women and 1 of 4 men over the age of 50.

BiologicsMD, from the University of Arkansas in Fayetteville, bested 41 other business plan teams at the world's richest and largest business plan competition, the Rice University Business Plan Competition, taking home more than $400,000 in cash and prizes.

This is the third year that the NASDAQ OMX Educational Foundation has sponsored the Rice Business Plan Competition and BiologicsMD is the third winning team to ring the bell. Representatives from NASDAQ OMX also judged the competition held April 15-17 this year at Rice University in Houston, Texas.

In honor of the occasion, representatives of Rice University and Biologics MD, LLC. will preside over the NASDAQ Closing Bell.

Who:

• Paul Mlakar, Chief Executive Officer of BiologicsMD, LLC.
• Misty Stevens, Chief Operating Officer of BiologicsMD, LLC.
• Michael Thomas, Chief Marketing Officer of BiologicsMD, LLC.
• Brad Burke, Managing Director of the Rice Alliance for Technology and Entrepreneurship, host of the competition
• Tracye McDaniel, Executive Vice President and Chief Operating Officer of the Greater Houston Partnership, competition sponsor
• David Brazda, Administaff, competition title sponsor
• staff of Rice Alliance for Technology and Entrepreneurship

Where:

NASDAQ MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:

Friday, June 25th, 2010 at 3:45 p.m. to 4:00 p.m. ET      

Contacts:

Mary Lynn Fernau

(713) 301-5494

mlfernau@rice.edu

NASDAQ MarketSite:

Robert Madden

(646) 441-5045

Robert.Madden@NASDAQOMX.com

Feed Information:

The Closing Bell is available from 3:50 p.m. to 4:05 p.m. on AMC-3/C-3 (ul 5985V; dl 3760H). The feed can also be found on Ascent fiber 1623. If you have any questions, please contact Robert Madden at (646) 441-5045.

Radio Feed:

An audio transmission of the Closing Bell is also available from 3:50 p.m. to 4:05 p.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Ascent fiber 1623 as well.

Facebook and Twitter:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:

http://www.facebook.com/pages/NASDAQ-OMX/108167527653

For news tweets, please visit our Twitter page at:

http://twitter.com/nasdaqomx

Webcast:

A live webcast of the NASDAQ Closing Bell will be available at:

http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos:

To obtain a high-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.

About NASDAQ OMX Educational Foundation:

The mission of The NASDAQ OMX Educational Foundation is to promote learning about capital formation, financial markets and entrepreneurship through innovative educational programs. It was established in New York City in 1994 and is supported entirely by contributions from The NASDAQ OMX Group, Inc.

About NASDAQ OMX:

The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries.  NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook (http://www.facebook.com/nasdaqomx) and Twitter (http://www.twitter.com/nasdaqomx).

About the Rice University Business Plan Competition:

The Rice University Business Plan Competition (RBPC) is the world's richest and largest business plan competition. During the competition's nine-year history, 36% of teams (97 out of 270 past competitors) have gone on to successfully launch their business. In 2009, 33 of the 42 teams launched their companies after competing at the RBPC. More than $223 million in early-stage funding has been raised by Rice Business Plan Competition participant companies with $75 million of that being raised in the last year alone. There are 200+ judges on the judging panel consisting of "who's who" of the investor, venture capital, entrepreneur, & business community.  

About BiologicsMD, LLC.:

BiologicsMD is developing OsteoFlor™, a new medication that builds better bones. Osteoporotic fractures strike 1 of 2 women and 1 of 4 men over the age of 50. Yet most current treatments, which constitute a $9 billion market, are not very effective at growing new bone. OsteoFlor™ binds directly to bone, nearly tripling new bone growth. It requires less frequent dosing and is expected to have few, if any, side effects. Our team's experience includes SBIR grant funding, medications development, FDA regulatory strategy, and start-up expansion. BiologicsMD is seeking $5 million over four years to take OsteoFlor™ through a Phase I clinical trial. A projected valuation of $160 million in 2014 represents a 45x return to early-stage investors. BiologicsMD.com

NDAQA

In This Story

NDAQ